ImmunoScape Pte. Ltd., an A*STAR spin out backed by Amgen Ventures and EDBi that is developing next-generation TCR-based cancer immunotherapies, today announced an exclusive in-licensing deal with Cue ...
The landscape of artificial intelligence (AI) funding continues its funding craze, marked by strategic investments across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback